Transcripts

Aquestive Therapeutics (AQST) earnings call transcripts

Earnings call transcripts for Aquestive Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed Anaphylm’s resubmission as substantially de-risked, while emphasizing focused launch preparation and expanding dermatology optionality.

    Aug 12, 2026Confident0.84